Huafu Securities released a research report on April 16 stating that the new industry (300832.SZ) was given a purchase rating, and the target price was 80.09 yuan. The main reasons for the rating include: 1) the company released its 2023 annual report, and the performance growth is in line with expectations; 2) domestic: level-III hospitals continue to expand, which is expected to benefit from collection implementation and increase market share; 3) overseas: installed capacity improvement+structural optimization, and continued impressive growth. (Mainichi Keizai Shimbun)
华福证券4月16日发布研报称，给予新产业（300832.SZ）买入评级，目标价格为80.09元。评级理由主要包括：1）公司发布2023年年度报告，业绩增长符合预期；2）国内：三级医院持续拓展，有望受益集采执行提升市占率；3）海外：装机提升+结构优化，持续亮眼高增。（每日经济新闻）
Huafu Securities released a research report on April 16 stating that the new industry (300832.SZ) was given a purchase rating, and the target price was 80.09 yuan. The main reasons for the rating include: 1) the company released its 2023 annual report, an
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.